| Revenue | 1B |
| Cost of sales | 336.94M |
| Gross margin | 666.69M |
| Research and development | 172.93M |
| Selling, marketing, general and administrative | 118.88M |
| Special charge | |
| Operating expenses | 309.71M |
| Operating income from continuing operations | 356.98M |
| Interest expense | 38.76M |
| Interest income | -7.11M |
| Other, net | 1.9M |
| Nonoperating (income) expense | 33.55M |
| Income from continuing operations before income taxes | 323.43M |
| Provision for income taxes | 27.28M |
| Income from continuing operations, net of tax | |
| Gain on sale of discontinued operations, net of tax | |
| Net income | 296.16M |
| Shares used to compute earnings per share - basic | -618.36M |
| Shares used to compute earnings per share - diluted | -625.29M |
| Basic earnings per share from continuing operations | |
| Basic earnings per share | |
| Diluted earnings per share from continuing operations | |
| Diluted earnings per share | |
| Dividends declared and paid per share | 0.42 |
| Includes stock-based compensation expense as follows: | |
| Stock-based compensation expense | 1.89M |
| Includes stock-based compensation expense as follows: | |
| Stock-based compensation expense | 7.01M |
| Includes stock-based compensation expense as follows: | |
| Stock-based compensation expense | 6.34M |